Jianmin Pan

3.6k citations
104 papers · 2.7k indexed · 1 hit paper · h-index 24
Topics
MicroRNA in disease regulation (13 papers)Breast Cancer Treatment Studies (10 papers)Cancer-related molecular mechanisms research (9 papers)
Partner nations
United StatesChinaIndia

In The Last Decade

Jianmin Pan

103 papers receiving 2.6k citations

Hit Papers

ROC-ing along: Evaluation and interpretation of receiver ...20162026201920222016100200300400500

Peers

Jianmin Pan
Comparison fields: 5 of 182
  • Molecular Biology 961
  • Cancer Research 776
  • Surgery 415
  • Oncology 375
  • Epidemiology 245
Replace Yan Zha with:
Yan Zha China
Wei He China
Mengling Liu United States
Lu Wang China
Xun� Li China
Eugene S. Kim United States
Ming Liu China
Wen Chen China
Meng Li China
Annie J. Sasco France
Jianmin Pan relative to Yan Zha China Yan Zha's profile →
Citations per field
00.5×2.9×
Yan Zha · 1×
Citations per year

Countries citing papers authored by Jianmin Pan

Since Specialization
Citations

This map shows the geographic impact of Jianmin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianmin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianmin Pan more than expected).

Fields of papers citing papers by Jianmin Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianmin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianmin Pan. The network helps show where Jianmin Pan may publish in the future.

Co-authorship network of co-authors of Jianmin Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Jianmin Pan. A scholar is included among the top collaborators of Jianmin Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianmin Pan. Jianmin Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 9
5 3
6 1
7 2
8 14
9 31
10 16
11 6
12 5
13 2
14 1
15 41
16 8
17 1
18 1
19 10
20 7

About Jianmin Pan

Jianmin Pan is a scholar working on Cancer Research, Statistics and Probability and Oncology, having authored 104 papers that have together received 2.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Breast Cancer Treatment Studies (10 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Cancer Research (776 citations), Reproductive Medicine (182 citations) and Molecular Biology (961 citations). Jianmin Pan has collaborated with scholars based in United States, China and India. Frequent co-authors include N. Shesh, Susan Galandiuk, Jane Carter, Henry L. Roberts, M. Robert Eichenberger, Ziad Kanaan, Kelly M. McMasters, Liling Fang, Jiahua Chen and Wei Chen. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026